Clinical trial IJB_2674
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy
Cancers | |
---|---|
Organ | Liver |
Trial status | Trial closed |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | Incyte Corporate |
EudraCT Identifier | 2016-002422-36 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02924376 |
Inclusion criteria | second line metastatic |
Last update |